CEFTRIAXONE
- CAS No.
- 73384-59-5
- Chemical Name:
- CEFTRIAXONE
- Synonyms
- CEFTRIAZONE;Ceftriazone sodiuM;Ceftriaxone Sodium Ep Impurity A;Rocefin;Biotrakson;Rocephin(e);CEFTRIAXONE;CEFATRIAXONE;Cefatriaxone From;Antibiotic Ro-13-9904
- CBNumber:
- CB9114533
- Molecular Formula:
- C18H18N8O7S3
- Molecular Weight:
- 554.58
- MOL File:
- 73384-59-5.mol
- Modify Date:
- 2024/8/1 23:06:22
Melting point | 155 °C |
---|---|
Density | 1.96±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C(protect from light) |
solubility | DMSO (Slightly), Methanol (Slightly) |
pka | pKa –3.2±0.6 (Uncertain);–1.8±0.2 (Uncertain);2.57±0.50 (Uncertain);2.90±0.50 (Uncertain);8.03±0.40 (Uncertain) |
form | Solid |
color | Off-White to Pale Yellow |
Stability | Hygroscopic |
CAS DataBase Reference | 73384-59-5(CAS DataBase Reference) |
EPA Substance Registry System | Ceftriaxone (73384-59-5) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07,GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H315-H317-H334-H319-H335 |
Precautionary statements | P261-P285-P304+P341-P342+P311-P501-P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501 |
Hazard Codes | Xn |
Risk Statements | 42/43 |
Safety Statements | 22-24-37-45 |
HS Code | 29349990 |
CEFTRIAXONE Chemical Properties,Uses,Production
Description
Ceftriaxone has the same C-7 side-chain moiety as cefotaxime and ceftizoxime, but the C-3 side chain consists of a metabolically stable and activating thiotriazinedione in place of the normal acetyl group. The C-3 side chain is sufficiently acidic that at normal pH, it forms an enolic sodium salt; thus, the commercial product is a disodium salt.
Uses
Ceftriaxone is an antibacterial, a third-generation cephalosporin.
Definition
ChEBI: A cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups.
Antimicrobial activity
Most β-lactamase-producing enterobacteria are highly susceptible, as are streptococci (but not enterococci) and fastidious Gram-negative bacilli, although brucellae are less sensitive (MIC 0.25–2 mg/L). Treatment failure has been reported in tularemia. Ps. aeruginosa, mycoplasmas, mycobacteria and L. monocytogenes are resistant.
Acquired resistance
Ceftriaxone is hydrolyzed by some chromosomal enzymes, including those of Enterobacter spp. and B. fragilis. Derepression of chromosomal β-lactamase production can cause resistance in some species of Gram-negative bacilli in vitro and has been observed in patients.
Clinical Use
Uses of Ceftriaxone are similar to those of cefotaxime, the long half-life offering the advantage of once-daily administration. It is used in the treatment of acute bacterial meningitis and as an alternative to rifampicin (rifampin) in the prophylaxis of meningococcal disease.
Side effects
Reactions are those common to other cephalosporins. Mention has been made of thrombocytopenia, thrombocytosis, leukopenia, eosinophilia abdominal pain, phlebitis, rash, fever and increased values in liver function tests. Diarrhea is common and suppression of the aerobic and anaerobic fecal flora has been associated with the appearance of resistant bacteria and yeasts.
Biliary pseudolithiasis due to concretions of insoluble calcium salt has been described in adults but principally in children. The precipitates can be detected in a high proportion of patients by ultrasonography and can occasionally cause pain, but resolve on cessation of treatment. Ceftriaxone is better avoided in patients with pre-existing biliary disease, but the principal hazard appears to be misdiagnosis of gallbladder disease and unnecessary surgery.
CEFTRIAXONE Preparation Products And Raw materials
Raw materials
1of4
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
PROTECH TELELINKS | +91-8571891912 +91-9855060837 | Himachal Pradesh, India | 62 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
Shinepro Life Sciences Private Limited | 08048981934 | Haryana, India | 3 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Hebei Lingding Biotechnology Co., Ltd. | +86-18031140164 +86-19933155420 | China | 452 | 58 | Inquiry |
Hebei Mojin Biotechnology Co., Ltd | +8613288715578 | China | 12459 | 58 | Inquiry |
Hebei Guanlang Biotechnology Co,.LTD | +86-19930503253; +8619930503252 | China | 5835 | 58 | Inquiry |
Shaanxi TNJONE Pharmaceutical Co., Ltd | +8618740459177 | China | 1142 | 58 | Inquiry |
Related articles
- Ceftriaxone: Antimicrobial Activity, Susceptibility, Administration and Dosage, Pharmacokinetics etc.
- Ceftriaxone (Ro 13-9904) is a 2-aminothiazolyl methoxyimino thirdgeneration cephalosporin derivative (Figure 27.1). Ceftriaxo....
- Mar 23,2022
73384-59-5(CEFTRIAXONE)Related Search:
1of4
chevron_right